Showing results (121-130 of 148) with videos related to
Sort By:
Pageof 15
The Lancet. Oncology|May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trialAlessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.Molecular Cancer Research : MCR|January 29, 2017
Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GISTMaria A Pantaleo, Milena Urbini, Valentina Indio, et al.Cancer|August 16, 2020
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWGWinan J van Houdt, Marco Fiore, Francesco Barretta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma GroupsAlessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.Molecular Cancer|August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.Journal of Surgical Oncology|December 28, 2020
Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Hannah L Tattersall, James Hodson, Kenneth Cardona, et al.Frontiers in Oncology|May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupDominga Racanelli, Monica Brenca, Davide Baldazzi, et al.The Lancet. Oncology|July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialSilvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.The Lancet. Oncology|December 23, 2018
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trialJavier Martin-Broto, Silvia Stacchiotti, Antonio Lopez-Pousa, et al.Pageof 15